Thoracic Cancer

Article	Citations
Issue Information	251
Issue Information	63
Issue Information	47
Correction to “The Prevalence, Distribution, and Clinicopathological Features of Seven Lung Cancer Actionable Driver Mutations in Taiwan”	40
Issue Information	39
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases	38
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma	37
Issue Information	34
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report	32
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report	31
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report	28
CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma	27
Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema	25
Comparison of Early Functional Recovery Following Triportal Robot‐Assisted and Uniportal Video‐Assisted Segmentectomy in Patients With Early‐Stage Non‐Small Cell Lung Cancer: A Propensity Score‐Matche	25
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements	25
Heterogeneity or transformation? A whack‐a‐mole case of EGFR‐mutant lung adenocarcinoma and small cell carcinoma: A case report	24
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1	24
Issue Information	24
A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring	23
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer	23
Sortilin‐1, Targeted by miR‐146a, Regulates the Behavior of Non‐Small Cell Lung Cancer	23
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation	22
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor	22
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China	22
PET–CT for visualizing the pathophysiology of COPD in patients with early‐stage NSCLC	21

Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study	21
Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report	21
Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report	21
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report	21
Evaluation of the inhibitory effect of azoles on pharmacokinetics of lenvatinib in rats both in vivo and in vitro by UPLC‐MS/MS	20
Pathological characteristics of lung tumors in Sri Lanka 2017–2021	20
Safety and efficacy of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) for patients aged 80 years and older	20
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction	20
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab	20
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells	19
Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer	19
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035	19
Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomize	19
Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer	19
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway	18
	18
Issue Information	18
Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors	18
Intrinsic resistance to ROS1 inhibition in a patient with CD74‐ROS1 mediated by AXL overexpression	18
Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer	18
Enhancing precision in lung tumor ablation through innovations in CT‐guided technique and angle control	18
Clinicopathological analysis of a superior sulcus tumor treated by salvage surgery after concurrent definitive chemoradiotherapy followed by durvalumab: A case report	18
Implication of IZUMO2 in the cell‐in‐cell phenomenon: A potential therapeutic target for triple‐negative breast cancer	17
Analysis of cytokines in bronchoalveolar lavage fluid in patients with checkpoint inhibitor pneumonitis and pulmonary infection: A case–control study	17
Adjuvant chemotherapy in patients with recurrence after completely resected stage IB lung adenocarcinoma: Propensity‐matched analysis in a cohort of 147 recurrences	17
PD‐1/PD‐L1 co‐location: A novel biomarker for immunotherapy response in non‐small cell lung cancer	17
Mixed micropapillary patterns found in malignant pleural mesothelioma with possibly worsened prognostic implication	17
Small‐cell lung cancer from the peripheral lung is frequently accompanied by emphysema and interstitial lung disease in the background	17
An Innovative Management in the Diagnosis of Mediastinal Masses	16
Treatment patterns and clinical outcomes of resectable clinical stage III non‐small cell lung cancer in a Japanese real‐world setting: Surgery cohort analysis of the SOLUTION study	16
Issue Information	16
Phase II study of IRInotecan treatment after COmbined chemo‐immunotherapy for extensive‐stage small cell lung cancer: Protocol of IRICO study	16
Non‐small cell lung carcinoma with focal coexpression of thyroid transcription factor‐1 and Δ Np63/p40: A case report	16
KIFC3 promotes the progression of non–small cell lung cancer cells through the PI3K/Akt pathway	15
Correction to “Stability and safety of transbronchial dye mixture for preoperative localization in a porcine model”	15
First‐Line Immune‐Combination Therapy for Driver Gene‐Negative NSCLC With Brain Metastases: Real‐World Outcomes	15
	15
Corrigendum	15
circFIG 4 drives the carcinogenesis and metastasis of esophagus cancer via the miR‐493‐5p/E2F3 axis	15
Issue Information	15
Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients	14
There Is More Than Meets the Eye With Ground Glass Nodules: Is It Too Early to Adopt Sublobar Resection as Standard of Care for Early Stage Lung Adenocarcinoma?	14
The regularity of anatomical variations of dominant pulmonary segments in the right upper lobe	14
Rare ashy dermatosis‐like hyperpigmentation associated with osimertinib	14
A targeted siRNA‐loaded PDL1‐exosome and functional evaluation against lung cancer	14
PICC Maintenance Challenges Among Esophageal Cancer Patients: A Qualitative Study	14
Serum cross‐linked N‐telopeptide of type I collagen as a potential diagnostic marker for bone metastasis in lung cancer: An updated meta‐analysis	14
Circ_0011292 knockdown mitigates progression and drug resistance in PTX‐resistant non‐small‐cell lung cancer cells by regulating miR‐433‐3p/CHEK1 axis	14
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR‐mutated NSCLC treated with afatinib	14
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy	14

Response Letter to “Management of Chylothorax Following Thoracic Surgery” by Busetto et al.	14
Development of a deep learning‐based method to diagnose pulmonary ground‐glass nodules by sequential computed tomography imaging	14
S‐ and R‐Carvedilol Prevent Benzo(a)pyrene‐Induced Lung Carcinogenesis	14
Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR‐6838‐5p	14
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma	14
Circ_0004140 promotes lung adenocarcinoma progression by upregulating NOVA2 via sponging miR‐330‐5p	13
Everolimus in combination with octreotide LAR in thymic atypical carcinoid	13
Issue Information	13
Issue Information	13
Potential activity of adiponectin‐expressing regulatory T cells against triple‐negative breast cancer cells through the cell‐in‐cell phenomenon	13
Prevalence and Correlates of Distress Detected by the Distress Thermometer and Problem List in Lung Cancer Patients: A Cross‐Sectional Study	13
Safety and feasibility of a novel chest tube placement in uniportal video‐assisted thoracoscopic surgery for non‐small cell lung cancer	13
Clinical Significance of Bone Metastases in Pleural Mesothelioma	13
The association of nutritional and inflammatory biomarkers with overall survival in patients with non‐small‐cell lung cancer treated with immune checkpoint inhibitors	13
Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non‐small cell lung cancer harboring BRAF V600E mutation: A	13
Predicting visceral pleural invasion in lung adenocarcinoma presenting as part‐solid density utilizing a nomogram model combined with radiomics and clinical features	13
	13
Characteristics and outcome of systemic treatment for metastatic or unresectable thymic carcinoma: A single institution experience	13
Chinese Expert Consensus on Leptomeningeal Metastases of Lung Cancer	13
Issue Information	13
SLC34A2 promotes cell proliferation by activating STX17‐mediated autophagy in esophageal squamous cell carcinoma	13
Revisiting ALK (D5F3) immunohistochemistry: Insights into focal staining and neuroendocrine differentiation	13
Efficacy and safety of anaplastic lymphoma kinase inhibitors for non–small cell lung cancer: A systematic review and network meta‐analysis	12
Issue Information	12
Segmentectomy Versus Lobectomy in Early Non‐Small Cell Lung Cancer: A Population‐Based Analysis in Northern Italy	12
Elevated BTG2 improves the radiosensitivity of non‐small cell lung cancer (NSCLC) through apoptosis	12
A novel evaluation model of image registration for cone‐beam computed tomography guided lung cancer radiotherapy	12
A case of concurrent follicular lymphoma and lung cancer requiring differentiation from lymph node metastasis	12
Issue Information	12
Issue Information	12
Association of Wearable Activity Monitors and Digital Drainage Device With Daily Ambulation and Length of Stay Among Pulmonary Resection Patients: A Prospective, Randomized Controlled Study	12
Chronic obstructive pulmonary disease assessment test for the measurement of deterioration and recovery of health status of patients undergoing lung surgery	12
Nivolumab as maintenance therapy following platinum‐based chemotherapy in EGFR‐mutant lung cancer patients after tyrosine kinase inhibitor failure: A single‐arm, open‐label, phase 2	12
Second primary tumor after immune checkpoint inhibitor therapy: A case report	12
Correction to “Safety and Efficacy of Radiotherapy Combined With Sintilimab in Advanced NSCLC Patients Who Progressed on First or Second Line Therapy: A Prospective, Multiple Center, and Si	12
Issue Information	12
	12
Feasibility of Endobronchial Ultrasound Guided Miniforceps Biopsy for PD‐L1 Expression and Quantitative Tissue Analysis	12
Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer	12
	12
	11
	11
Using MRI radiomics to predict the efficacy of immunotherapy for brain metastasis in patients with small cell lung cancer	11
Clinical Outcomes of Later‐Generation EGFR ‐ TKIs for Uncommon EGFR	11
Esophageal cancer: Outcome and potential benefit of esophagectomy in elderly patients	11
Issue Information	11
A case of bilateral synchronous double primary lung cancer secondary to bladder cancer: From the next‐generation sequencing prospect	11
Circ_0003340 downregulation mitigates esophageal squamous cell carcinoma progression by targeting miR‐940/PRKAA1 axis	11
Resected stage I anaplastic lymphoma kinase‐positive lung adenocarcinoma has a negative impact on recurrence‐free survival	11
CORRECTION	11
	11
Issue Information	11
Clinicopathological features and prognosis of mucinous breast carcinoma with a micropapillary structure	11
Mutations and expressions of breast cancer 1/2 in lung cancer	11
Examination of the effectiveness of local therapy for oligo‐recurrence of EGFR‐mutated NSCLC	11
Response to dabrafenib plus trametinib on a rare BRAF mutation (V600_W604 deletion–insertion R) in an advanced non‐small cell lung cancer patient	11
Ventilation challenge in rigid bronchoscopy: Laser tube as an alternative management in patients with lung cancer and central airway obstruction	11
Mucoepidermoid carcinoma cured by a combination of high‐frequency snare and photodynamic therapy: A case report	11
Quantitative analysis of imaging characteristics in lung adenocarcinoma in situ using artificial intelligence	11
Issue Information	11
Radiological and pathological analysis of the galaxy sign in patients with pulmonary mucosa‐associated lymphoid tissue (MALT) lymphoma	11
Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study	11
Real‐World Evidence That Non‐Smokers With High PD‐L1 Non‐Squamous NSCLC Have Poorer Outcomes With Immune Checkpoint Inhibitors	11
“Separated” precise subsegmentectomy: Single‐port thoracoscopic noncombined subsegmentectomy in one lung lobe	11
Platinum‐combination chemotherapy with or without immune‐checkpoint inhibitor in patients with postoperative recurrent non‐small cell lung cancer previously treated with adjuvant platinum‐doublet chem	11
A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer	11
Chylothorax After Thoracic Surgery: How We Manage It	11
Update on therapeutic strategy for esophageal anastomotic leak: A systematic literature review	10
The utility of bispectral index monitoring in flexible bronchoscopy: A single‐center, retrospective observational study	10
The impact of COVID‐19 on new mesothelioma diagnoses in Italy	10
METTL3‐mediated the m6A modification of SF3B4 facilitates the development of non‐small cell lung cancer by enhancing LSM4 expression	10
Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR‐622/SLC1A5 signaling axis	10
Frequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non‐Small Cell Lung Cancer	10
Unprecedented long‐term survival in a patient with malignant pleural mesothelioma treated with subsequent systemic chemo‐ and immunotherapeutic regimens	10
Epithelial‐Mesenchymal Plasticity in the D‐Meso‐Sonobe Mesothelioma Cell Line: A Putative Model of Epithelial–Mesenchymal Transition in Mesothelioma	10
Multiple micromeningiomas coexist with primary lung adenocarcinoma: A case report	10
Tumor‐derived exosomal miR‐148b‐3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion	10
Partial Stereotactic Ablative Radiotherapy Boost Before Conventional Radiotherapy (P‐SABR) for Large (> 5 cm) Unresectable Stage III Nonsmall Cell Lung Cancer	10
Epidemiological characteristics and therapeutic advances of EGFR exon 20 insertion mutations in non‐small cell lung cancer	10
Impact of Antibiotic on Efficacy and Adverse Reactions of Chemoimmunotherapy in Non‐small Cell Lung Cancer Patients: A Retrospective Cohort Study	10

Treatment and mortality risk of older adults with non‐small cell cancer in Taiwan: A population‐based cohort study	10
Real‐World Analysis of Treatment Patterns in Limited‐Stage Small Cell Lung Cancer: Implications for Clinical Practice	10
Burden of Breast Cancer and Its Attributable Risk Factors in the Belt and Road Initiative Countries, 1990–2021	10
Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma	10
Circular RNA, circular RARS, promotes aerobic glycolysis of non‐small‐cell lung cancer by binding with LDHA	10
Bronchiolar adenoma/ciliated muconodular papillary tumor mixed with adenocarcinoma in situ in the same tumor	10
Impact of sarcopenia on the prognosis of patients with advanced non‐small cell lung cancer treated with antiangiogenic therapy: A propensity score matching analysis	10
Three‐dimensional lung reconstructions for the localization of lung nodules to be resected during surgery	10
The response prediction and prognostic values of systemic inflammation response index in patients with advanced lung adenocarcinoma	10
Neoadjuvant Glucocorticoids Facilitate Resection in Advanced B‐Type Thymomas: A Propensity‐Matched Analysis of Surgical and Survival Outcomes	10
Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of Thymoma	10
Nondiagnostic, radial‐probe endobronchial ultrasound‐guided biopsy for peripheral lung lesions: The added value of radiomics from ultrasound imaging for predicting malignancy	10
Real‐world study of treatment and outcome of type B2 + B3 thymoma: The neglected part of thymoma	10
Factors affecting long‐term survival of non‐small‐cell lung cancer patients with concomitant type 2 diabetes mellitus	10
A propensity sore‐matched study: Applying a modified chest tube drainage strategy in rapid rehabilitation following uni‐portal thoracoscopic pulmonary wedge resection	10
Chronic hyperglycemia is an adverse prognostic factor for locoregional recurrence‐free survival in small cell lung cancer patients treated with radical radiotherapy	9
Circ‐EIF3I facilitates proliferation, migration, and invasion of lung cancer via regulating the activity of Wnt/β‐catenin pathway through the miR‐1253/NOVA2 axis	9
Puncture frequency predicts pneumothorax in preoperative computed tomography‐guided lung nodule localization for video‐assisted thoracoscopic surgery	9
Significance of Platinum‐Based Chemotherapy With Programmed Death‐1 Blockade in Limited Disease Small Cell Lung Cancer: A Retrospective Study	9
Immune Signatures of Solid Tumor Patients Treated With Immune Checkpoint Inhibitors: An Observational Study	9
	9
Efficacy and safety of second‐line chemotherapy for patients with advanced non‐small cell lung cancer complicated by interstitial lung disease	9
Issue Information	9
Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR‐mutated lung adenocarcinoma	9
GIMAP7 inhibits epithelial‐mesenchymal transition and glycolysis in lung adenocarcinoma cells via regulating the Smo/AMPK signaling pathway	9
Downregulation of PD‐L1 and HLA‐I in non‐small cell lung cancer with ALK fusion	9
Remarkable response to pazopanib plus vivolumab in a patient with pericardial synovial sarcoma carrying a novel genotype BRCA2 c.968dupT: A case report	9
Prognostic impact of tumor volume in patients with complete resection of thymoma	9
Radiation‐induced pseudomembranous tracheobronchitis: A report of two cases	9
Identification of the intersegmental plane via electromagnetic navigation for anatomical segmentectomy	9
Liquid biopsy assay for pulmonary adenocarcinoma using supernatants from core‐needle biopsy specimens	9
	9
Activation of circ_0072088/miR‐1261/PIK3CA pathway accelerates lung adenocarcinoma progression	9
	9
Factors affecting accuracy of clinical staging in resectable non‐small cell lung cancer in a real‐world study	9
Different clinical characteristics and survival between surgically resected pure and combined small cell lung cancer	9
Synchronous resection of 12 small pulmonary nodules guided by a noninvasive 3D printed emulation model: A case report	9
New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB‐III) lung cancer: The standard uptake values ratio of ipsilateral/contralate	9
Bronchiolar adenoma/ciliated muconodular papillary tumor complicated by lymphoid interstitial pneumonia in a patient with Sjögren's disease: A case report and systematic review	9
Circulation of rare events in the liquid biopsy for early detection of lung mass lesions	9
	9
	9
	9
Lepidic growth component as a favorable prognostic factor in non–small cell lung cancer of ≤3 cm	9
The predictive value of the preoperative systemic immune‐inflammation index in the occurrence of postoperative pneumonia in non‐small cell lung cancer: A retrospective study base	9
Prognostic Impact of Tumor Solid Components in Stereotactic Body Radiotherapy for Clinical Stage Tis–1N0M0 Lung Cancer	9
Division of the intersegmental demarcation using the “modified hand‐tearing method” is safe and feasible in thoracoscopic anatomical segmentectomy	9
Chinese expert consensus on cone‐beam CT‐guided diagnosis, localization and treatment for pulmonary nodules	9
SCLC and anti‐GABABR encephalitis: A retrospective analysis of 60 cases in China	9
	8
Disease activity of lung cancer at the time of acute exacerbation of interstitial lung disease during cytotoxic chemotherapy	8
	8
Coronavirus disease 2019 (COVID‐19) in patients before, during, or after lung irradiation, and serum SP‐A and SP‐D levels	8
	8
MiR‐379‐5p inhibits the proliferation, migration, and invasion of breast cancer by targeting KIF4A	8
Early patient‐reported outcomes after robotic‐assisted versus video‐assisted thoracoscopic lobectomy	8
	8
Hyperprogressive disease in lung metastases without target lesion progression after durvalumab consolidation therapy: A case report	8
Exosome‐delivered circSATB2 targets the miR‐330‐5p/PEAK1 axis to regulate proliferation, migration and invasion of lung cancer cells	8
ACT001 Suppresses the Malignant Progression of Small‐Cell Lung Cancer by Inhibiting Lactate Production and Promoting Anti‐Tumor Immunity	8
A phase II, multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (st	8
Phase III, multicenter, randomized trial of 45 Gy versus 30 Gy thoracic radiation for extensive‐stage small cell lung cancer (ES‐SCLC): Study protocol	8
	8
Hyperprogression of a spindle‐cell squamous carcinoma of the esophagus after esophagectomy	8
Issue Information	8
Prophylactic cranial irradiation in patients with resected small‐cell lung cancer: A systematic review and meta‐analysis	8
Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR‐136‐5p/YWHAZ axis	8
A CT‐based radiomics model to predict subsequent brain metastasis in patients with ALK‐rearranged non–small cell lung cancer undergoing crizotinib treatment	8
USP22 promotes gefitinib resistance and inhibits ferroptosis in non‐small cell lung cancer by deubiquitination of MDM2	8
	8
Is wedge resection equivalent to segmentectomy in pathological stage IA (≤2 cm) non‐small cell lung cancers?	8
Association Between Baseline Neutrophil Count and Febrile Neutropenia Following Docetaxel and Ramucirumab With Prophylactic Pegfilgrastim	8
The immune microenvironment of lung adenocarcinoma featured with ground‐glass nodules	8
Therapeutic Effect of Lymph Node Dissection After Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy on Esophageal Squamous Cell Carcinoma Using the Efficacy Index	8
	8
Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer	8
Issue Information	8
Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity	8
Issue Information	8
Long‐term stability of pleural fluid carcinoembryonic antigen and its effect on the diagnostic accuracy for malignant pleural effusion	8
Benefits of camrelizumab plus carboplatin and albumin paclitaxel as induction therapy for locally advanced borderline resectable or unresectable esophageal squamous cell carcinoma	8
Solitary extramedullary plasmacytoma of the left main bronchus: A case report and literature review	8
	8
Addition of metformin to non‐small‐cell lung cancer patients with or without diabetes	8
Comparing Needle and Surgical Biopsy in Small Peripheral Non‐Small Cell Lung Cancer With Suspected Pleural Invasion: A Propensity Score‐Matched Study	8
Impact of concurrent medications on the outcome of immunotherapy in non‐small cell lung carcinoma	8
Miliary brain metastases from lung adenocarcinoma with EGFR (L858R) and CTNNB1 mutations	8
AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines	7
Postoperative Lung Function Advantages in Pulmonary Segmentectomy for Early‐Stage Lung Cancer	7
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids	7
Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?	7
One‐way endobronchial valves in the management of complex persistent air leaks in a soft tissue sarcoma patient	7
Pulmonary completion lobectomy after segmentectomy: An integrated analysis of perioperative outcomes	7
Challenges of the eighth edition of the American Joint Committee on Cancer staging system for pathologists focusing on early stage lung adenocarcinoma	7
Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge	7